Free tool
Oncology stocks
We cover 97 companies grouped under the Oncology theme. The median market value in the group is $22.72M. Across the group, the median move over the past trading day is −0.61%. 34% of the 96 with a 200-day average trade above it. Price change over the past year runs from −90.9% to +50.4% across the middle 80 percent of the group, with a median of −42.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
97 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | 143.10 BRL | −2.15% | −13.50% | +0.13% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| BNTX | BioNTech SE | $112.56 | +21.75% | +16.41% | +9.27% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% |
| JATT | JATT II Acquisition Corp. | $12.01 | +7.81% | +14.38% | +14.38% |
| ACRV | Acrivon Therapeutics, Inc. | $2.08 | +35.06% | −15.45% | +52.94% |
| MAIA | MAIA Biotechnology, Inc. | $1.39 | +12.10% | −13.13% | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.91 | −9.07% | −40.84% | −13.25% |
| CTOR | Citius Oncology, Inc. | $0.79 | +45.49% | −27.12% | −62.34% |
| ELTX | Elicio Therapeutics, Inc. | $2.98 | +1.02% | −62.98% | −71.29% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $0.98 | +20.01% | −63.00% | −54.65% |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% |
| XBIT | XBiotech Inc. | $2.31 | +1.76% | −2.94% | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| XLO | Xilio Therapeutics, Inc. | $9.05 | −1.09% | −3.81% | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $0.31 | −36.29% | −75.22% | −77.04% |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% |
| TIL | Instil Bio, Inc. | $7.83 | +7.41% | −30.52% | −72.04% |
| IBO | Impact BioMedical Inc. | $0.44 | +2.35% | −15.20% | −24.12% |
| BKHA | Black Hawk Acquisition Corporation | $11.85 | −2.09% | +5.31% | +7.70% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $1.96 | −72.36% | −72.74% | −74.90% |
| CNTX | Context Therapeutics Inc. | $0.42 | −28.31% | −72.66% | −50.73% |
| BCT.TO | BriaCell Therapeutics Corp. | 5.62 CAD | +15.64% | −42.77% | −46.48% |
| BCTX | BriaCell Therapeutics Corp. | $4.03 | +16.14% | −43.79% | −46.97% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| ATNM | Actinium Pharmaceuticals, Inc. | $1.01 | +16.49% | −26.28% | −42.61% |
| MDNA.TO | Medicenna Therapeutics Corp. | 0.47 CAD | +32.39% | −53.00% | −56.48% |
| BYSI | BeyondSpring Inc. | $0.69 | −41.77% | −57.14% | −62.09% |
| CVM | CEL-SCI Corporation | $1.61 | +34.17% | −68.74% | −87.65% |
| LTRN | Lantern Pharma Inc. | $2.18 | −16.15% | −29.90% | −46.17% |
| NXTC | NextCure, Inc. | $5.83 | +7.56% | −56.10% | +11.37% |
| EVAX | Evaxion A/S | $3.24 | +15.71% | −31.21% | +6.93% |
| PSTV | Plus Therapeutics Inc | $3.84 | +2.07% | −72.59% | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $2.65 | +9.50% | −71.96% | −76.75% |
| MRKR | Marker Therapeutics, Inc. | $1.45 | +22.88% | −5.84% | +54.26% |
| CLRB | Cellectar Biosciences, Inc. | $2.54 | +1.60% | −26.80% | −47.30% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| CCM | Concord Medical Services Holdings Limited | $4.96 | +7.83% | +16.16% | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $1.34 | +13.56% | +17.54% | −15.72% |
| ABVC | ABVC BioPharma, Inc. | $0.71 | −32.92% | −67.53% | −76.14% |
| RADX | Radiopharm Theranostics Limited | $2.32 | −29.91% | −55.04% | −58.87% |
| TPST | Tempest Therapeutics, Inc. | $1.08 | +24.00% | −63.39% | −89.96% |
| AKTX | Akari Therapeutics, Plc | $9.10 | +7.95% | −21.55% | −72.42% |
| MDCX | Medicus Pharma Ltd. | $0.27 | −4.11% | −83.22% | −86.77% |
| CTXR | Citius Pharmaceuticals, Inc. | $0.58 | +15.88% | −31.95% | −57.88% |
| LSTA | Lisata Therapeutics, Inc. | $1.74 | +50.00% | −11.22% | −30.40% |
| INTS | Intensity Therapeutics, Inc. | $4.53 | −0.44% | −55.48% | −40.00% |
| PHIO | Phio Pharmaceuticals Corp. | $1.20 | +18.81% | +10.09% | −40.89% |
| GTBP | GT Biopharma, Inc. | $0.29 | −8.49% | −64.49% | −74.55% |
| PDSB | PDS Biotechnology Corporation | $0.22 | −67.70% | −73.21% | −82.56% |
| APRE | Aprea Therapeutics, Inc. | $0.98 | +59.61% | +14.89% | −38.75% |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% |
| MBRX | Moleculin Biotech, Inc. | $0.60 | −72.60% | −83.43% | −96.05% |
| TOVX | Theriva Biologics, Inc. | $0.24 | +15.81% | −6.46% | −42.10% |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.79% | −71.71% | −89.34% |
| IMNN | Imunon, Inc. | $1.63 | +6.54% | −58.73% | −73.10% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| CNSP | CNS Pharmaceuticals, Inc. | $5.44 | +7.30% | +2.64% | −13.51% |
| AIM | AIM ImmunoTech Inc. | $0.25 | +4.17% | −78.34% | −89.69% |
| BOLT | Bolt Biotherapeutics, Inc. | $3.92 | −2.49% | −32.30% | −26.73% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| CANF | Can-Fite BioPharma Ltd. | $3.32 | +5.06% | −24.55% | −74.85% |
| ITOC | iTonic Holdings Ltd. | $0.29 | +11.89% | −33.23% | −59.75% |
| NCNA | NuCana plc | $1.53 | +18.60% | −57.97% | −52.78% |
| LIMN | Liminatus Pharma, Inc. | $4.41 | +4140.38% | +587.99% | +46.03% |
| PCSA | Processa Pharmaceuticals, Inc. | $2.13 | −30.16% | −27.30% | −60.00% |
| KAPA | Kairos Pharma, Ltd. | $0.26 | −15.58% | −64.33% | −77.97% |
| BCAB | BioAtla, Inc. | $3.12 | −11.61% | −88.31% | −86.04% |
| HCWB | HCW Biologics Inc. | $2.70 | +4.45% | +141.07% | −55.15% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
| APVO | Aptevo Therapeutics Inc. | $2.41 | −42.76% | −74.33% | −92.52% |
| OSRH | OSR Health, Inc. | $0.17 | −63.24% | −71.48% | −80.93% |
| CRIS | Curis, Inc. | $1.54 | −68.12% | +57.14% | −5.52% |
| RDHL | RedHill Biopharma Ltd. | $0.62 | −15.71% | −40.26% | −53.74% |
| CLDI | Calidi Biotherapeutics, Inc. | $1.35 | −21.14% | +14.41% | −19.16% |
| GOVX | GeoVax Labs, Inc. | $0.63 | −13.33% | −87.82% | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $0.71 | −19.25% | −81.35% | −97.37% |
| PPBT | Purple Biotech Ltd | $1.73 | +26.28% | −73.79% | −92.21% |
| NXTS | Nexentis Technologies Inc. | $1.88 | +21.29% | −83.11% | −96.40% |
| RNAZ | TransCode Therapeutics, Inc. | $2.34 | −53.20% | −68.38% | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $1.07 | −11.57% | −92.51% | −98.54% |
| SLXN | Silexion Therapeutics Corp | $0.35 | −85.51% | −81.12% | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $3.01 | −25.50% | −61.53% | −95.78% |
| BDRX | Biodexa Pharmaceuticals Plc | $0.98 | −32.13% | −92.05% | −96.58% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.